Literature DB >> 27925819

The Affordable Care Act Transformation of Substance Use Disorder Treatment.

Amanda J Abraham1, Christina M Andrews1, Colleen M Grogan1, Thomas D'Aunno1, Keith N Humphreys1, Harold A Pollack1, Peter D Friedmann1.   

Abstract

Mesh：

Year:  2017        PMID： 27925819      PMCID： PMC5308192          DOI： 10.2105/AJPH.2016.303558

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  5 in total

1.  A political history of federal mental health and addiction insurance parity.

Authors:  Colleen L Barry; Haiden A Huskamp; Howard H Goldman
Journal:  Milbank Q       Date:  2010-09       Impact factor: 4.911

2.  Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Authors:  Colleen M Grogan; Christina Andrews; Amanda Abraham; Keith Humphreys; Harold A Pollack; Bikki Tran Smith; Peter D Friedmann
Journal:  Health Aff (Millwood)       Date:  2016-12-01       Impact factor: 6.301

3.  The Affordable Care Act will revolutionize care for substance use disorders in the United States.

Authors:  Keith Humphreys; Richard G Frank
Journal:  Addiction       Date:  2014-06-26       Impact factor: 6.526

4.  Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

Authors:  Rose A Rudd; Noah Aleshire; Jon E Zibbell; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-01       Impact factor: 17.586

5.  The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.

Authors:  Curtis S Florence; Chao Zhou; Feijun Luo; Likang Xu
Journal:  Med Care       Date:  2016-10       Impact factor: 2.983
  5 in total
  30 in total

1.  Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act.

Authors:  He Zhu; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2019-02-16       Impact factor: 4.492

2.  Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis.

Authors:  Aimee N C Campbell; Dennis McCarty; Traci Rieckmann; Jennifer McNeely; John Rotrosen; Li-Tzy Wu; Gavin Bart
Journal:  J Subst Abuse Treat       Date:  2018-11-19

3.  Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.

Authors:  Babak Tofighi; Arthur Robin Williams; Chemi Chemi; Selena Suhail-Sindhu; Vicky Dickson; Joshua D Lee
Journal:  Subst Use Misuse       Date:  2019-08-20       Impact factor: 2.164

4.  Medicaid coverage in substance use disorder treatment after the affordable care act.

Authors:  Christina M Andrews; Harold A Pollack; Amanda J Abraham; Colleen M Grogan; Clifford S Bersamira; Thomas D'Aunno; Peter D Friedmann
Journal:  J Subst Abuse Treat       Date:  2019-04-09

5.  Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.

Authors:  Andrew S Huhn; J Gregory Hobelmann; Justin C Strickland; George A Oyler; Cecilia L Bergeria; Annie Umbricht; Kelly E Dunn
Journal:  JAMA Netw Open       Date:  2020-02-05

6.  Association of Medicaid Expansion and Health Insurance with Receipt of Smoking Cessation Services and Smoking Behaviors in Substance Use Disorder Treatment.

Authors:  Deborah Yip; Noah Gubner; Thao Le; Denise Williams; Kevin Delucchi; Joseph Guydish
Journal:  J Behav Health Serv Res       Date:  2020-04       Impact factor: 1.505

7.  Predictors of availability of long-acting medication for opioid use disorder.

Authors:  Chelsea L Shover; Keith Humphreys
Journal:  Drug Alcohol Depend       Date:  2019-09-25       Impact factor: 4.492

8.  Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.

Authors:  Ashly E Jordan; Charles M Cleland; Katarzyna Wyka; Bruce R Schackman; David C Perlman; Denis Nash
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

9.  Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system.

Authors:  Derek D Satre; Vanessa A Palzes; Kelly C Young-Wolff; Sujaya Parthasarathy; Constance Weisner; Joseph Guydish; Cynthia I Campbell
Journal:  J Subst Abuse Treat       Date:  2020-08-04

10.  On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.

Authors:  Sydney M Silverstein; Raminta Daniulaityte; Shannon C Miller; Silvia S Martins; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-03-16       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.